For the panel to consolidate cases into an MDL, the actions must involve one or more common questions of fact
The STEP 5 trial showed that patients who stopped semaglutide after 68 weeks regained approximately 2 pounds per month over the following year, while those on maintenance therapy held steady
Regular ophthalmologic examinations should constitute a non-negotiable component of treatment protocols, particularly for patients presenting with diabetes or pre-existing vascular conditions
Read Stephen's story below
Eligibility for the Medicare GLP-1 Bridge will also be limited to Medicare beneficiaries who have not filled a prescription under their Part D plan for a GLP-1 in 2026, and who do not have a diagnosis with a condition that is a medically accepted indication for a GLP-1 drug that could be covered under Part D (specified by CMS as type 2 diabetes, obstructive sleep apnea (OSA), and noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH)), even if they otherwise meet the clinical criteria
doi: 10.1093/ajcn/80.5.1123 220